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Abstract
Mutations in the human mitochondrial elongation factor G1 (EF-G1) are recessive lethal and cause death shortly after birth.
We have isolated mutations in iconoclast (ico), which encodes the highly conserved Drosophila orthologue of EF-G1. We find
that EF-G1 is essential during fly development, but its function is not required in every tissue. In contrast to null mutations,
missense mutations exhibit stronger, possibly neomorphic phenotypes that lead to premature death during embryogenesis.
Our experiments show that EF-G1 contains a secondary C-terminal nuclear localization signal. Expression of missense
mutant forms of EF-G1 can accumulate in the nucleus and cause growth and patterning defects and animal lethality. We
find that transgenes that encode mutant human EF-G1 proteins can rescue ico mutants, indicating that the underlying
problem of the human disease is not just the loss of enzymatic activity. Our results are consistent with a model where EF-G1
acts as a retrograde signal from mitochondria to the nucleus to slow down cell proliferation if mitochondrial energy output
is low.
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Introduction
Birth defects due to problems in mitochondrial function affect a
large number of children. Many are associated with mutations in
genes involved in the translation of proteins in mitochondria
required for oxidative phosphorylation, which supplies approxi-
mately 90% of the energy used by eukaryotic cells. There are five
protein complexes in mitochondria that are required for this
process: four comprise the mitochondrial respiratory chain and
complex V functions as ATP synthase [1]. While all five complexes
contain proteins derived from nuclear genes, complexes I, III, IV,
and V also contain a total of thirteen proteins encoded within the
mitochondrial DNA [2]. The biosynthesis of these proteins
requires several nuclear-encoded factors, which are translated in
the cytoplasm and imported into mitochondria [3]. Mutations in
these factors severely impact mitochondrial function, since they
impede the synthesis of all thirteen proteins encoded in the
mitochondrial DNA and affect all but complex II. For example,
the fatal pediatric disorder Combined Oxidative Phosphorylation
Deficiency 1 (COXPD1) is caused by mutations in a single gene
that encodes the human mitochondrial translation elongation
factor G1 (EF-G1). Children with mutations in EF-G1 suffer from
early onset Leigh’s syndrome, lactic acidosis, exhibit severe
neurological defects, and typically die shortly after birth due to
liver failure [4,5,6]. Currently, the underlying problem of this
disease is not well understood. Previous findings have shown that
cells in tissues affected by the disease exhibit reduced levels of EF-
G1 protein in mitochondria [5]. However, it is not clear whether
the mutant forms of EF-G1 are degraded or not imported into
mitochondria.
In this report, we describe the identification and characteriza-
tion of mutations in the Drosophila orthologue of EF-G1, iconoclast
(ico). The ico locus was identified in suppressor and enhancer
screens for mutations that interact with TGF-beta signaling. Our
analysis reveals that ico is an essential gene but not required in
every tissue. Interestingly, missense alleles exhibit a much more
severe phenotype than null mutations. When expressed from
transgenes, we find that mutant EF-G1 proteins, which encode a
secondary C-terminal nuclear signal sequence, are not degraded
and can translocate to the nucleus and inhibit growth and disrupt
patterning. Taken together, out results are consistent with a model
where EF-G1 may function as a retrograde signal from mitoch-
ondria to the nucleus to prevent cell proliferation, if mitochondrial
ATP synthesis is too low.
Results
EMS-mutations in ico interact with DPP signaling
Polypeptide cytokines of the TGF-beta family contribute to a
wide range of developmental and physiological functions in higher
eukaryotes. Among many functions, this diverse group of signaling
molecules promotes growth and controls cell death [7]. In a
genetic screen for mutations that interact with an activated form of
the TGF-beta type I receptor Thick Veins (TKV), we isolated
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excess TKV signaling in wings [8,9]. When tested in a second
maternal enhancer screen, only a few these mutations were able to
reduce signaling of the ligand Decapentaplegic (DPP) and cause
embryonic lethality in combination with the allele dpp
hr4 [10].
Among the mutations that strongly interacted with DPP signaling in
both screens we identified alleles of the downstream transcription
factors mad and medea, the Glypican dally, and the not characterized
mutation II032. This mutation was originally isolated in a large
scale mutagenesis screen for recessive embryonic lethal genes [11].
Since the gene affected by this mutation had not been identified, we
named this locus, which is located on the left arm of chromosome 2
(L2), iconoclast (ico). We tested, whether mutations from a different
mutagenesis screen that were mapped to this location failed to
complement II032 mutants, and identified three additional alleles of
ico, G
A1, G
A25, and B
A18 [12]. Homozygous and transheterozygous
combinations of all four ico alleles are embryonic lethal and die
within 24 hours with head involution defects (Figure 1A and B). In
addition, heterozygous mutants of all four alleles cause lethality in
combination with dpp
hr4, indicating that they reduce DPP signaling
(Figure 1C and D).
Ico encodes CG4567, the Drosophila orthologue of the
mitochondrial elongation factor G1
Complementation tests with well-defined deficiencies on L2
indicated that the mutations might be located within CG4567,
which encodes the Drosophila orthologue of the mitochondrial
elongation factor G1 (dEF-G1; Figure 2). To identify the gene, we
generated imprecise excisions of various P-elements including
EY05983, which is located 39 of CG4567. We isolated two
deletions, ico
Del EY1 and ico
Del EY2, which failed to complement ico
alleles. Subsequent sequencing revealed that the EMS-induced
mutations contained single or double missense mutations in
various regions of CG4567 (Figures 2 and 3). Both deletions
remove the C-terminal RNA binding domains of CG4567
(Figure 3), which according to structural comparison mimic the
shape of a tRNA and are used to interact with ribosomes [13].
Thus, the deletion mutations most likely represent null mutations,
since the resulting truncated proteins are not expected to form
functional complexes with ribosomes. Although the allele ico
Del EY2
also lacks a portion of the neighboring gene CG13784, the
phenotypes of the two deletions are identical. Interestingly,
homozygous or transheterozygous animals of the two deletions
are not embryonic lethal like the four missense mutations but
develop for two additional days to the early third instar larval
stage, where they arrest development and die several days later.
Animals with a combination of a missense mutation and a deletion
die shortly after embryogenesis as malformed first instar larvae. In
contrast to missense mutations, the two deletions also do not
interact with DPP signaling in both genetic screens. Taken
together, our results show that ico alleles are mutations in CG4567
and that missense mutations that encode full-length EF-G1
proteins cause a more severe phenotype than null mutations.
Rescue of ico mutants with human EF-G1 transgenes
To further confirm that ico alleles are mutations in CG4567,w e
generated transgenic flies with the CG4567 coding region under
the control of the upstream activating sequences of GAL4 to
perform mutant rescue experiments (pUAST and pUAST2 [14,15]).
In addition, we made transgenic flies that express the highly
conserved human EF-G1 orthologue (hEF-G1, Figure 2), the
CG4567-G538E protein made in II032 mutants (Figure 3), the
previously characterized human mutant proteins hEF-G1-N174S
and hEF-G1-S321P (Figure 3), as well as the Drosophila orthologue
of EF-G2, CG31159 (dEF-G2, Figure 2). When expressed
ubiquitously with a combination of the armadillo and daughterless
GAL4 drivers (arm+da-GAL4), we find that the fly and human wild
type transgenes are able to rescue close to 100% of ico mutant
animals (Table 1, row 1, 2, and 6). This result confirms that ico
alleles are mutations in CG4567 and that the functions of the EF-
G1 proteins are conserved between flies and humans. Compared
to the wild type transgenes, the CG4567-G538E mutant form
retains little activity, since ubiquitous expression of this protein is
unable to rescue a single mutant animal to adulthood (Table 1,
row 4). In contrast, more than 80% of expected mutant animals
are rescued by the human mutant form N174S [4], indicating that
this mutant form retains a high level of functional activity in flies
(Table 1, row 7). However, we noticed that the first animals
rescued by this transgene hatch 3 to 5 days later than heterozygous
animals or animals rescued with wild type transgenes. A delay of at
Figure 1. EMS-mutant ico alleles are embryonic lethal and interact with DPP signaling. (A–D) Cuticle preparations of dead embryos. (A and
B) Homozygous or transheterozygous combinations of the ico alleles II032, G
A1, G
A25, and B
A18 die as embryos with head involution defects. (C and D)
Animals heterozygous for ico EMS-mutant alleles are embryonic lethal in combination with dpp
hr4, indicating that they exhibit reduced DPP signaling.
doi:10.1371/journal.pone.0016799.g001
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transgenes that encode the mutant hEF-G1-S321P [5]. Compared
to N174S, only 40% of the expected animals survive to adulthood
(Table 1, row 8), suggesting that the S321P mutant proteins retain
less activity than N174S. In contrast to the fly and human EF-G1
transgenes, no animals were rescued with a single or two recom-
bined transgenes that express the Drosophila EF-G2 protein
(Table 1, row 9 and 10). As in tissues of COXPD1 patients [5],
it appears that overexpression of EF-G2 cannot compensate for
the absence of EF-G1.
The function of EF-G1 is not required in the eye
The deletions ico
Del EY1 and ico
Del EY2 remove a large portion of
the EF-G1 C-terminal region that is likely essential for its function
[16]. However, these null mutations live substantially longer than
flies with alleles encoding full-length proteins with missense
mutations, suggesting that the proteins derived from missense
mutations cause additional defects. To further investigate
differences between deletion and missense mutations, we com-
pared the fates of homozygous clones of ico mutants in somatic
cells of the eye, a tissue that is not essential for viability. Using the
FRT/Flipase system [17], we recombined ico mutants with an
FRT containing transgene close to the centromere of 2 L. When
the site-specific recombination enzyme Flipase is expressed under
the control of eyeless regulatory sequences in eyes of a heterozygous
animal with two FRT sites at the same position on both sister
chromosomes, somatic recombination of the chromosomal arms
can occur during mitosis, resulting in daughter cells that contain
two wild type or two mutant copies. To distinguish the
homozygous ico clones generated by this process from the
homozygous wild type clones and non-recombined heterozygous
cells, this experiment is performed in a white background with a
mini-white transgene on 2 L to mark the heterozygous ico cells with
red pigment. Since the ico mutant clones could exhibit reduced
proliferation rates and might be out-competed by the wild type
and heterozygous cells, a recessive cell-lethal mutation is located
on 2 L of the sister chromosome to eliminate homozygous
clones that are wild type for ico. Since the Flipase is located on
the X-chromosome, only females will undergo recombination in
the eye. Heterozygous cells that do not recombine express the
mini-white transgene and are red. Homozygous twin clones of the
sister chromosome should die due to the cell-lethal mutation.
Homozygous clones of ico mutants are white, since they do not
inherit the mini-white transgene.
The absence of white cells in heterozygous II032 animals
suggests that homozygous clones of this missense mutation do not
survive to adulthood (Figure 4A). The size of the eyes is reduced
and patterning is disrupted, since the recombined cells die and
only non-recombined cells survive and proliferate. Compared to
II032, a few small white clones appear in the eyes of G
A1, B
A18, and
G
A25 mutant animals (Figure 4B-D, arrow), indicating that these
mutations severely affect cell proliferation or survival rates. G
A25
mutant animals exhibit the largest number of white cells,
suggesting that it is the weakest of the missense mutations
(Figure 4D). In contrast to missense mutations, the eyes of the
deletion mutations ico
Del EY1 and ico
Del EY2 show no pattern defects
and contain large areas of white homozygous clones (Figure 4E
and F). The finding that cellular clones of ico mutants that almost
certainly represent null mutations develop normally and do not
disrupt patterning of the eyes indicates that the function of
Drosophila EF-G1 is not required in the eye and possibly other
tissues. Since elongation is an essential process and all eukaryotes
encode a second highly conserved mitochondrial G factor, EF-G2,
it is possible that Drosophila EF-G2 can compensate for the lack of
EF-G1 in certain tissues like the eye. Taken together, our results
demonstrate that the presence of ico missense mutations has
deleterious effects on cell proliferation or survival even in tissues
where Drosophila EF-G1 is apparently not required.
Figure 3. The identified mutations in EF-G1 are located in various domains. Similarities between EF-G1 and bacterial G-factors indicate that
the proteins likely share a similar three-dimensional structure [20]. The first and largest domain of EF-G1 is its GTP-GDP binding domain. Six of the
identified mutations are located in this domain. The second domain shares homology to the elongation factor EF-Tu. Domains IV and V show
similarities with other RNA binding proteins, and structural analysis suggests that Domains III, IV, and V form an interface mimicking the shape of a
tRNA that is used to interact with ribosomes [13]. In addition to bacterial G-factors and mitochondrial EF-G2 proteins, EF-G1 contains a positively
charged C-terminal tail. The deletion EY1 removes 1888 nucleotides, which creates a stop codon six amino acids after P314 and encodes a truncated
protein that only consists of the first domain. Similarly, deletion EY2 removes 3663 nucleotides, which creates a stop codon 19 residues past C367 and
encodes a protein truncated within domain II.
doi:10.1371/journal.pone.0016799.g003
Figure 2. Sequence alignment of Drosophila and human EF-G1 and EF-G2 proteins. Sequence alignment of the Drosophila and human EF-
G1 and EF-G2 proteins (dEF-G1, hEF-G1, dEF-G2, hEF-G2). The positions of the identified fly and human EF-G1 mutations shown in Figure 3 are
indicated by numbers (1–11) [4,5,6].
doi:10.1371/journal.pone.0016799.g002
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eyes of G
A1, B
A18, and G
A25 mutant animals (Figure 4B–D). The
latter three mutations were all induced in a black and cinnabar
background [12]. However, since darker spots are also present in
the eyes of the other alleles, they may represent twin clones. This is
only possible, if the cell-lethal gene on the sister chromosome is not
entirely lethal. Since two copies of the mini-white gene cannot
cause this color, it can only be explained if an additional
undisclosed recessive eye color marker is present on that
chromosome. Whatever the cause is for these patches, they do
not affect the interpretation of the presented results.
Expression of an EF-G1 missense mutant form causes
growth and patterning defects in wings
To further investigate the deleterious effects of EF-G1 missense
mutant proteins, we expressed the II032 mutant form CG4567-
G538E in various tissues. While animals that ubiquitously express
two wild type ico transgenes with daughterless-GAL4 develop
normally, we find that wild type animals that express two copies
of CG4567-G538E all die before pupation, further supporting the
idea that full-length mutant EF-G1 proteins can cause additional
defects. When expressed in wings, a tissue that is not essential for
viability, we find that CG4567-G538E transgenes cause growth and
pattern defects. Compared to wild type wings (Figure 5A), wings
that express two or four CG4567-G538E transgenes under the
control of ptc-GAL4 exhibit normal proportions but show reduced
growth in the area between longitudinal veins 3 and 4 where the
mutant proteins are expressed (Figure 5B). In addition, the mutant
transgenes also prevent the formation of the anterior crossvein in
this area (Figure 5B, arrow). When expressed ubiquitously with the
wing driver A9-GAL4, two copies of CG4567-G538E clearly
disrupt wing growth, which leads to patterning defects such as
ectopic vein formation and the merging of longitudinal veins
(Figure 5D). In comparison, we noticed that ubiquitous expression
of two wild type CG4567 transgenes also reduces growth
(Figure 5C). Although we did not quantify the average reduction
in growth, the major difference between wild type and mutant
transgenes is the absence of pattern defects in wings that express
wild type transgenes.
One major structural difference between EF-G1 and EF-G2 is
the presence of a short positively charged C-terminal tail that is
absent in EF-G2 (Figure 2). To assess its role in growth inhibition,
we generated and expressed EF-G1 proteins that lack the C-
terminal tail. We find that expression of three UAS-CG4567-DCstop
transgenes have no significant effects on wing growth and
patterning (Figure 5E). This result is not due to the lack of
enzymatic function, since transgenes that encode the tailless EF-
G1 protein are still able to rescue ico mutants (Table 1, row 5).
Similarly, compared to two full-length mutant transgenes
(Figure 5D), wings that express three mutant transgenes without
the C-tail show less severe growth defects and no major vein
patterning defects (Figure 5F). Unlike two copies of the full-length
mutant transgenes, we also find that expression of three copies of
the tailless mutant transgenes in all tissues with daughterless-GAL4
does not cause developmental arrest and lethality. Finally, we
would like to note that overexpression of four copies of EF-G2
does not result in lethality or any wing phenotype (data not
shown). Taken together, these results indicate that the unique C-
terminal tail of EF-G1 contributes to the growth and pattern
defects caused by EF-G1 missense mutant proteins.
The C-terminal tail of EF-G1 functions as a nuclear
localization signal
Previous experiments in tissues of human patients have shown
that the underlying problem of the COXPD1 disease is caused by
the absence of mutant EF-G1 protein in affected tissues. In the
case of the human S321P mutation, the mutant protein cannot be
detected in mitochondria of the liver and muscles [5]. In contrast,
reduced but significant amounts are still present in mitochondria
of the heart, a tissue that is not affected by the disease. The authors
favored a model where reduced protein levels are the result of
decreased stability and consequent degradation of the mutant EF-
G1 proteins. However, human mutant proteins show significant
activity in rescue experiments, indicating that they are reasonably
stable. If EF-G1 proteins encoded by missense mutations are
stable, absent from mitochondria in certain tissues, and can cause
growth and pattern defects, it is possible that the observed defects
are the result of EF-G1 accumulation outside of mitochondria.
To investigate the subcellular localization of wild type and
mutant EF-G1 proteins, we generated constructs with epitope tags.
We modified a pUAST vector to allow expression of GFP and
GST-tagged EF-G1 and EF-G2 proteins with or without the
mitochondrial target protein sequence (TP) in flies and Schneider
2 (S2) tissue culture cells (NheI, TP, MssI, GFP/GST, NaeI,
protein of interest, XbaI, BglII). The finding that a transgene that
Table 1. Rescue of ico mutants by fly and human EF-G1
proteins.
Adults Rescue
UAS-CG4567/w; ico
GA1 ico
Del EY2; +/arm+da-GAL4
UAS-CG4567/w; CyO/ico
Del EY2; +/arm+da-GAL4
67
70
67/70=
96%
UAS-CG4567/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-CG4567/w; CyO/ico
Del EY2; +/arm+da-GAL4
72
70
72/70=
103%
UAS-TP-GFP-CG4567/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-TP-GFP-CG4567/w; CyO/ico
Del EY2; +/arm+da-GAL4
65
70
65/70=
93%
UAS-CG4567-G538E/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-CG4567-G538E/w; CyO/ico
Del EY2; +/arm+da-GAL4
0
102
0/102=
0%
UAS-CG4567-DCstop/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-CG4567-DCstop/w; CyO/ico
Del EY2; +/arm+da-GAL4
61
66
61/66=
92%
UAS-hEF-G1/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-hEF-G1/w; CyO/ico
Del EY2; +/arm+da-GAL4
67
73
67/73=
92%
UAS-hEF-G1-N174S/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-hEF-G1-N174S/w; CyO/ico
Del EY2; +/arm+da-GAL4
74
92
74/92=
80%
w/w; ico
Del EY1/ico
Del EY2; UAS-hEF-G1-S321P/arm+da-GAL4
w/w; CyO-TM6B/ico
Del EY2; arm+da-GAL4
38
95
38/95=
40%
UAS-CG31159/w; ico
Del EY1/ico
Del EY2; +/arm+da-GAL4
UAS-CG31159/w; CyO/ico
Del EY2; +/arm+da-GAL4
0
111
0/111=
0%
w/w; ico
Del EY1/ico
Del EY2; UAS-CG31159 (2x)/arm+da-GAL4
w/w; ico
Del EY2; CyO-TM6B/arm+da-GAL4
0
97
0/97=
0%
Females with ico mutations and fly or human transgenes on the X or third
chromosome (UAS-EF-G1/UAS-EF-G1; ico/CyO; +/+ or w/w; ico; UAS-EF-G1/CyO-
TM6B) were crossed to males with ico mutations and the ubiquitous GAL4
drivers armadillo-GAL4 and daughterless-GAL4 balanced over chromosomes
with dominant curly wing and tubby body markers (w/Y; ico
Del EY2; arm+da-
GAL4/CyO-TM6B). The numbers of the rescued homozygous ico mutant females,
which have straight wings and are not tubby, were compared to their
heterozygous ico sisters, which have curly wings. (Row 3) TP-GFP-CG4567
transgenes that express a GFP-tagged Drosophila EF-G1 protein inserted after
the N-terminal target sequence (TP) encode a functional protein that can rescue
ico mutants. (Row 4, 9, and 10) Transgenes that express the II032 mutant EF-G1
or Drosophila EF-G2 (CG31159) proteins do not rescue ico mutants. (Row 5)
CG4567-DCstop is a transgene with a premature stop codon that lacks the C-
terminal tail. (Row 7 and 8) The adults rescued with hEF-G1-N174N and hEF-G1-
S321P hatched at least 3-5 days later than their siblings did. (Row 8 and10) The
number of the animals rescued with the hEF-G1-S321P or CG31159 transgenes
was compared to curly and tubby animals with the darker eye color of the
arm+da-GAL4.
doi:10.1371/journal.pone.0016799.t001
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mutants shows that insertion of a tag at this location does not
disrupt mitochondrial targeting and the activity of the protein
(Table 1, row 3). If the TP sequence is omitted, the coding region
initiates from a start codon within GFP or GST. Consequently,
such fusion proteins should not be imported into mitochondria. If
no protein sequence is inserted at the NaeI site, a stop codon
terminates the coding sequence of GFP or GST.
To express the fusion proteins in S2 cells, the pUAST2
constructs were co-transfected with a plasmid that expresses
GAL4 under the control of the actin5C promoter and enhancer.
Four days after transfection, we were able to detect robust
expression of GFP without a TP in the cytosol as well as in the
nucleus of S2 cells using a confocal microscope (Figure 6A).
Compared to GFP alone, expression of GFP-CG4567 or the
mutant GFP-CG4567-G538E without the TP is predominantly
nuclear (Figure 6B and C). In contrast, removal of the C-tail
reverts to a mixed cytosolic and nuclear expression pattern
(Figure 6D). An EF-G2 fusion protein (GFP-CG31159) that lacks
the TP shows a similarly mixed expression pattern (Figure 6E).
However, when the tail of CG4567 is added to the C-terminus of
CG31159, we again observe a predominantly nuclear localization
of the protein (Figure 6F). When the TP is added to GFP or GFP-
CG4567, the expression pattern dramatically changes to a
punctate pattern that likely corresponds to mitochondria
(Figure 6G and H), since TP-GFP-CG4567 encoding transgenes
are able to rescue ico mutant flies (Table 1). A similar pattern is
seen with the mutant TP-GFP-CG4567-G538E (Figure 6I).
However, in contrast to the wild type TP-GFP-CG4567 protein,
a faint signal of the mutant protein can be detected in the nucleus
(Figure 6H and I, arrows). The finding that only the mutant
protein can be detected in the nucleus suggests that the presence of
the mutant proteins affects the efficiency of EF-G1 import into
mitochondria in wild type cells.
Since GFP by itself can localize to the nucleus, we used proteins
tagged with the bacterial GST to further supplement our
subcellular localization analysis. Unlike GFP, GST-tagged proteins
are monitored with an anti-GST-FITC antibody (green). For this
procedure, the cells have to be fixed, which leads to cells adhering
to each other, making it more difficult to monitor single cells.
Using DAPI (blue) and MitoTracker (red) as marker for the
nucleus and mitochondria respectively, we find that GST-CG4567
without the TP exclusively localizes to the nucleus (Figure 6J).
Nuclear localization is completely lost, if the C-tail of EF-G1 is
removed (Figure 6K). On the other hand, GST-CG31159 without
the TP is entirely cytoplasmic but shifts to the nucleus if the
CG4567 C-tail is added (Figure 6L and M). In the presence of the
TP, the GST-CG4567 co-localizes predominantly with mitochon-
dria that form aggregates due to fixation (Figure 6N, green+
red=yellow). While TP-GST-CG4567-G538E is also imported
into mitochondria (Figure 6O, yellow), a significantly larger
amount of the mutant protein is found outside of mitochondria if
compared to the wild type protein (compare Figure 6N and O,
green). Taken together, our analysis of GFP and GST fusion
proteins shows that EF-G1 has two localization signals, an N-
terminal mitochondrial target signal and a C-terminal nuclear
signal. In the presence of both signals, wild type EF-G1 proteins
are imported into mitochondria and no significant amounts are
detected in the nucleus (Figure 6H and N). The proteins expressed
by the missense mutant transgenes used in this study are not
Figure 4. Clonal analysis of ico mutants in the eye. Clones of homozygous ico alleles were generated with eyeless-Flipase in the eyes of females.
Homozygous ico clones do not contain eye pigment and are white. Pigmented cells are heterozygous for ico. (A) Clones of the mutation II032 do not
survive to adulthood. (B–D) Clones of the other three missense mutations exhibit a small numbers of white cells. In contrast, homozygous clones of
the two null mutations develop normally (E and F), indicating that EF-G1 function is not required in the eye and that clones expressing C-terminally
truncated proteins do not affect growth and patterning. The cause for the black patches of cells that can be clearly seen in G
A1, B
A18, and G
A25 but are
also present in the other alleles is not entirely clear. However, their presence does not affect the interpretation of the results. See text for details.
doi:10.1371/journal.pone.0016799.g004
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compared to the wild type protein (Figure 6H and N), the mutant
form is not only imported into mitochondria but also accumulates
outside of mitochondria, where it can translocate into the nucleus
(Figure 6I and O).
Discussion
The defects caused by EF-G1 missense mutations
correlate with the presence of a nuclear localization
signal
The characterization of mutations in the Drosophila mitochon-
drial translation elongation factor G1 reveals that, as in humans, it
is an essential gene. Animals homozygous for ico null mutations are
able to survive on maternal contribution to the larval stages but fail
to initiate the rapid growth phase during the third larval stage,
which is not surprising given the role of EF-G1 in mitochondrial
biosynthesis and the high energy demands during that phase. In
contrast, animals with EF-G1 missense mutations die prematurely
during embryogenesis, indicating that alleles that express full-
length mutant EF-G1 proteins exhibit gain-of-function pheno-
types. The finding that clones of missense mutants in the eye rarely
survive while clones of deletion mutants develop normally further
supports this notion. In addition, mutant ico transgenes cause
larval lethality when overexpressed in all tissues and inhibit growth
and disrupts patterning when expressed in wings. Taken together,
these results suggest that full-length mutant EF-G1 proteins have
dose-dependent negative effects on cell proliferation and cell
survival. The observations that the C-terminal tail can function as
a nuclear localization signal and that overexpression of wild type
EF-G1 proteins can also reduce wing growth suggest a model,
where EF-G1 functions as a retrograde signal to arrest the cell cycle,
if the level of ATP synthesis in mitochondria is insufficient for
proliferation. In this model, almost all wild type EF-G1 is imported
into mitochondria, if they generate normal levels of ATP. However,
if mitochondrial ATP synthesis is low or EF-G1 is overexpressed
and import of EF-G1 proteins into mitochondria is a limiting step,
some EF-G1 proteins can accumulate outside of mitochondria and
translocate into the nucleus, where they inhibit cellular growth and
proliferation. If mutant EF-G1 proteins are expressed in wild type
cells, they likely bind to ribosomes and interfere with mitochondrial
translation, which results in reduced ATP synthesis, which causes a
decrease of EF-G1 import into mitochondria and accumulation of
the protein outside of mitochondria in the nucleus (Figure 6I and
O). In contrast, overexpression of wild type EF-G1 proteins is not
expected to interfere with mitochondrial translation. They can only
accumulate in the nucleus, if overexpression increases the level of
wild type EF-G1 high enough to overwhelm mitochondrial import.
Consistent with such a model, expression of wild type EF-G1
proteins is compared to missense mutant proteins not lethal and
does not cause pattern defects (compare Figure 5 C and D). In
addition,wild typetransgeneswithoutthe C-terminaltailcanrescue
Figure 5. Expression of mutant EF-G1 forms reduces growth and affects patterning in wings. (A) Heterozygous A9-GAL4/+ female wing
with wild type patterning. Longitudinal veins L1-L5 and the anterior and posterior crossveins are indicated (AC, PC). (B) Wings that express four
CG4567-G538E transgenes encoding the EF-G1 protein of II032 mutants with ptc-GAL4 show normal proportions but exhibit reduced growth between
L3 and L4 where the mutant protein is expressed. They also lack the anterior crossvein (arrow). (C) Overexpression of two wild type ico transgenes in
wings using A9-GAL4 does not affect patterning but results in smaller wings. (D) In comparison, ubiquitous expression of two CG4567-G538E
transgenes reduces growth and interferes with proper vein formation. (E) Expression of three EF-G1 transgenes that lack the C-terminal tail has no
apparent effects on growth or patterning. (F) Compared to two full-length mutant transgenes (D), expression of three tailless mutant CG4567-G538E
transgenes results in no major pattern defects but reduces the size of wings.
doi:10.1371/journal.pone.0016799.g005
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wild type or mutant forms without the C-terminal tail have less
severe effects on growth and patterning than the full-length proteins
when expressed at high levels in wings (compare Figure 5C and E,
5D and 5F). Similarly, ubiquitous expression of two mutant
transgenes with the C-tail is lethal, while expression of three
transgenes without the tail is not. Taken together, these results show
that the nuclear localization signal strongly contributes to the
toxicity of the mutant EF-G1 proteins, suggesting that accumulation
of EF-G1 in the nucleus is responsible for the observed defects.
Currently, the mechanism whereby nuclear EF-G1 proteins
affect these tissues remains unclear. We have found that animals
heterozygous for ico missense mutations suppress the overprolifera-
tion and pattern defects caused by expression of a constitutively
activated form of the DPP type I receptor TKV in wings.
Similarly, ico missense mutations reduce DPP signaling in embryos
Figure 6. The C-terminal tail of EF-G1 functions as a nuclear localization signal. (A–I) Subcellular localization of GFP tagged EF-G1 (CG4567)
and EF-G2 (CG31159) proteins in living S2 cells. (A) GFP is found in the cytoplasm and the nucleus. (B) GFP-tagged EF-G1 that lacks the N-terminal
mitochondrial target sequence predominantly localizes to the nucleus. (C) The mutant CG4567-G538E also mainly localizes to the nucleus. (D) In
contrast, when the C-terminal tail of EF-G1 is removed, the GFP-tagged protein is found again in the cytoplasm. (E) Similarly, Drosophila EF-G2 is
cytosolic and nuclear. (F) Addition of the CG4567 C-tail to EF-G2 enhances its nuclear localization. (G) Addition of the N-terminal mitochondrial target
protein sequence (TP) of EF-G1 results in punctate GFP staining. (H) A similar punctate pattern is seen with a GFP-tagged EF-G1 protein that contains
the TP. (I) While punctate staining is also seen with the mutant CG4567-G538E, one can detect a faint signal of the protein in the nucleus (arrow,
compare to H). (J–O) Co-localization of GST-tagged EF-G1 and EF-G2 proteins (green) with DAPI (blue, nucleus) and MitoTracker (red, mitochondria) in
fixed S2 cells. (J) A GST-tagged EF-G1 protein without the TP exclusively localizes to the nucleus. (K) Removal of the C-tail of EF-G1 changes the
subcellular localization from the nucleus to the cytoplasm. (L) Unlike EF-G1, EF-G2 without the TP is found in the cytoplasm. (M) Addition of the EF-G1
C-tail to EF-G2 alters the subcellular localization from the cytoplasm to the nucleus. (N) A GST-tagged EF-G1 protein with the N-terminal TP co-
localizes with MitoTracker in mitochondria that aggregate due to fixation (green+red=yellow). (O) The mutant TP-CG4567-G538E also localizes to
mitochondrial aggregates (yellow). However, in contrast to the wild type protein, significant amounts of the mutant protein are also detected outside
of mitochondria (green).
doi:10.1371/journal.pone.0016799.g006
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terminal tail do not interact with DPP signaling in embryos or
wings. The finding that only full-length EF-G1 proteins with the
nuclear localization signal can inhibit growth and DPP signaling
suggests that EF-G1 proteins have a function in the nucleus
downstream of DPP signaling. However, it is not clear whether
these effects are DPP specific or shared with other growth
promoting pathways. Additional research using Drosophila as a
model system should be able to provide better insights into the
growth inhibitory mechanism of EF-G1.
The role of EF-G1 and EF-G2 in flies and humans
Although ico is expressed in most tissues (Flybase and
unpublished data), the lack of any visible defects in eye clones of
ico deletion mutants, which lack the necessary domains for proper
interactions with ribosomes and likely lack elongation activity,
suggests that EF-G1 may not be required in all tissues. Since
translation of mitochondria-encoded proteins is an essential
process, this result also suggests that another protein can perform
the function of EF-G1 in its absence. The best candidate for such a
function is the EF-G2, which is present in all eukaryotic cells from
yeast to humans. However, overexpression of EF-G2 cannot
rescue ico mutants (Table 1). Similarly, human EF-G2 cannot
compensate for the loss of EF-G1 in affected tissues of COXPD1
patients [5]. On the other hand, ubiquitous expression of EF-G1
cannot rescue the pupal lethal phenotype of flies with reduced EF-
G2 levels due to gene silencing (unpublished results). A recent
publication analyzing the functions of EF-G1 and 2 in bacteria
and in liver tissues suggested that EF-G2 does not function in
elongation but ribosomal recycling [16]. Taken together, these
data indicate that EF-G1 and EF-G2 perform distinct functions.
Although EF-G1 and EF-G2 undeniably exhibit non-overlap-
ping roles, the current data do not rule out the possibility that EF-
G2 is an elongation factor. It is possible that EF-G2 can catalyze
elongation but only in mitochondria of certain tissues. The finding
that the loss of EF-G1 does not affect eye development can be
explained if Drosophila EF-G2 assumes the function of elongation in
the eye. If the elongation activity of EF-G2 is restricted to certain
tissues, overexpression of EF-G2 is not expected to rescue ico
mutants or substitute for EF-G1 in tissues affected in COXPD1
patients. This scenario would also explain why EF-G2 was shown
to have no elongation activity in the liver [16], a tissue highly
affected by the loss of EF-G1 [5].
In human patients, the loss of EF-G1 does not cause pathology
in all tissues. In COXPD1 patients, the mutant EF-G1 protein was
found to be present at reduced levels in mitochondria of non-
affected tissues like the heart but non-detectable in mitochondria
of tissues with severely reduced mitochondrial function like the
liver [5]. Our rescue experiments show that the human mutant
hEF-G1-N174S and hEF-G1-S321P proteins are stable and retain
activity in flies. Taken together, these data suggest that EF-G1
import is reduced in all tissues of COXPD1 patients and that the
levels of EF-G1 import indicates whether mitochondrial transla-
tion occurs sufficiently in a tissue.
This raises the question of why the import of mutant EF-G1 is
reduced. If EF-G2 functioned as an elongation factors in tissues
like the heart, mitochondrial translation and ATP synthesis would
occur at normal levels, and EF-G1 would be imported into
mitochondria and not accumulate in the nucleus. On the other
hand, in tissues like the liver, where EF-G2 cannot function as an
elongation factor, mitochondrial translation would decrease, ATP
levels would drop, EF-G1 import into mitochondria would
decrease and accumulation in the nucleus increase, which would
further exacerbate the problem. Although this model is consistent
with the current data, it is highly speculative at this moment, and
additional experiments are required to further explore this
hypothesis in flies and humans.
Materials and Methods
Mutant analysis
If not indicated otherwise, fly strains were obtained from the
Bloomington stock center. The missense mutant allele ico
II032 was
created by EMS mutagenesis [11]. The alleles ico
BA18, ico
GA1,a n d
ico
GA25 were induced by EMS in a black and cinnabar background
[12]. To analyze the cuticles of mutant animals, embryos were
dechorionated, mounted in Hoyer’s medium, and incubated at
65uC for 5 hours. The deletion alleles ico
Del EY1 and ico
Del EY2 were
generated by mobilization of the P-element EY05983, isolated by
complementation testing using the Exelixis lines Df(2L)Exel8019,
Df(2L)Exel6017, and Df(2L)Exel7031, and confirmed through PCR
using the primers: 59TTTCCCTATTGCTCTCGCACG and
59ACAGAGTTCTATCCCAGATGAG.
Molecular biology
All alleles were sequenced by Davis Sequencing (Davis, CA).
The transgenic constructs were sequenced by Retrogen, Inc. The
sequence alignment was performed using the ClustalW function of
the MacVector bioinformatics program (Figure 2). The accession
number for the CG4567 (ico) mRNA is NM135261 and NM
024996 for the human EF-G1 (GFM1) mRNA. The annotated
sequence of CG31159 (Drosophila EF-G2) is slightly different from
our isolated cDNA, which has been submitted to NCBI.
The transgenic construct for wild type ico was created from a
cDNA with a PCR extension from a Drosophila cDNA library [18]
using the primers 59ACAGAGTTCTATCCCAGATGAG and
59GCGCCTCGAGCTAGTTCTTCTTTTTCTTCTTGTC, and
cloned into the BglII and XhoI sites of pUAST [14].
The C-terminal deletion form CG4567DCstop was generated by
PCR using the C-terminal primer GGCCTAGGCCAATCCTTGC-
GACTCC.
The human EF-G1 constructs were generated using a clone from
ATCC (#10436473). The human EF-G1 cDNA was PCR amplified
from this clone using the primers 59GTGCGGTACCGGCAGCT-
GAACCCAC and 59GCCTCTAGAGTCAGTCAACTCACAG-
TAAG, and the fragment was cloned into the Asp718 and XbaI sites
of pUAST2 [15].
A Drosophila EF-G2 cDNA (CG31159) was amplified from an
embryonic library [18] using the primers 59TTTAGATCT-
GAAAATGCTGAAATATGCATGGC and 59GGCCGCTAGC-
TATTCAAGGCCCTGTGCTCTGandcloned into the BglIIand
XbaI sites of pUAST.
The mutant CG4567-G538E, hEF-G1-N174S, and hEF-G1-
S321P transgenic constructs were created by site-directed mutage-
nesis on the wild type constructs using the QuikChange method
(Stratagene, La Jolla, CA).
The GFP and GST-tagged constructs were generated by
cloning PCR-fragments of GFP and GST into pUAST2 (NheI,
TP, MssI, GFP or GST, NaeI, protein of interest, XbaI, BglII).
Fusion proteins were generated by fusion of C-terminal fragment
to a unique NaeI site introduced in GFP and GST. The
mitochondrial target sequence was added by cloning a fragment
in front of GFP or GST using NheI (in pUAST2) and MssI (in GFP
and GST).
Transgenic constructs were sequenced by Retrogen and injected
by Genetic Services. The transgenic constructs were tissue-
specifically expressed using the GAL4 driver lines described in
the text.
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In order to generate eye clones homozygous for ico mutations,
crosses were performed as follows for each of the six ico mutant
alleles: white, eyeless-Flipase/Y; mini-white, cell-lethal(2L) FRT(2L)/CyO
males were crossed to white/white; ico, FRT(2L)/CyO females. Since
the Flipase is located on the X-chromosome, recombination only
occurs in the eyes of female progeny that was examined for the
presence of white, non-colored cells derived from recombinant
clones of homozygous ico mutants.
Analysis of the subcellular localization of EF-G1 and 2
proteins in tissue culture cells
A GAL4 cDNA was cloned into pAcpA, which contains the
Actin5C promoter and polyA regions [19]. 2610
6 Schneider 2
(S2) cells were co-transfected with 1 mgo factin5C-GAL4 and 1 mg
of the pUAST-EF-G1 and pUAST-EF-G2 DNAs. After four days,
the expression of GFP-tagged proteins was analyzed with a Nikon
confocal microscope. Cells that express GST-tagged proteins were
incubated after four days with DAPI (Sigma) and MitoTracker
(Invitrogen M7512) for one hour, fixed with PBS/4% formalde-
hyde for 20 minutes, and detected using a FITC coupled anti-
GST Antibody (GenWay 18-272-197537) with the confocal
microscope.
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